Healthcare

Nicotine Transdermal Patches Market Study Offering Deep Insight Related to Growth Trends Until 2026

Global Nicotine Transdermal Patches Market: Overview

A nicotine patch is a device that delivers nicotine into the body through the skin. This patch is usually used to help prevent nicotine cravings that smokers experience when trying to quit smoking. This type of drug delivery system is generally known as a transdermal patch. The patch comprises a drug reservoir inserted between a permeable adhesive layer and an occlusive back layer that attaches to the skin. The drug slowly percolates out of the reservoir. It travels through the skin and then goes to the blood stream. A nicotine transdermal patch is used in nicotine replacement therapy. Nicotine replacement therapy uses devices that release controlled and low quantities of nicotine, without the release of harmful ingredients found in tobacco such as carbon monoxide and tar.

Obtain Report Details @ https://www.transparencymarketresearch.com/nicotine-transdermal-patches-market.html

In 1980, nicotine patches were developed by a health care researcher’s team in California. The team discovered that nicotine can be absorbed through the skin, and they found that the effects of this can help reduce cravings for cigarettes in smokers. In 1988, the researchers filed a patent for transdermal nicotine patches. Nicotine patches are one of the most popular smoking aids in the market at present. Tobacco use is the leading cause of disability, death, and preventable disease in the U.S. According to the Centers for Disease Control and Prevention (CDC), about 40 million U.S. adults smoke cigarettes. Additionally, about 4.7 million high school and middle school students use at least one tobacco product, such hookah and e-cigarettes. Every year, the U.S. spends nearly US$ 170 Bn on medical care to treat smoking- related disease in adults.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=62505

Global Nicotine Transdermal Patches Market: Key Trends

The global nicotine transdermal patches market is expected to expand rapidly during the forecast period, due to an increase in awareness about the benefits of using nicotine patches. When nicotine is consumed in appropriate quantities, it proves to be helpful. Nicotine patches are an obvious choice for health conscious customers who want to quit smoking. The latest trend driving the global nicotine transdermal patches market is an increase in activities and promotional campaigns for smoking cessation aids. For instance, the U.S. Department of Health and Human Services is running a campaign called Fresh Empire. It is the FDA’s first public education campaign designed to reduce and prevent tobacco usage among at-risk youth between the ages of 12 and17 years who identify with hip-hop culture, specifically Asian American/Pacific Islander, Hispanic, and African American youth. However, side effects of nicotine patches are projected to restrain the global nicotine transdermal patches market during the forecast period.

Global Nicotine Transdermal Patches Market: Segmentation

The global nicotine transdermal patches market can be segmented based on product and region. Based on product, the global nicotine transdermal patches market can be classified into 16-hour nicotine patch and 24-hour nicotine patch. The 24-hour nicotine patch segment is expected to account for a key market share. This is due to an increase in demand for 24-hour nicotine patch variants such as 7mg, 14 mg, and 21 mg.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=62505

Global Nicotine Transdermal Patches Market: Regional Analysis

Based on region, the global nicotine transdermal patches market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. Asia Pacific is expected to be a rapidly expanding region of the global nicotine transdermal patches market. The global nicotine transdermal patches market is expected to be driven by an increase in awareness among people regarding diseases and side effects caused by smoking and increase in government initiatives and new policies for the development of health care infrastructure.

Global Nicotine Transdermal Patches Market: Competitive Landscape

Key players operating in the global nicotine transdermal patches market include GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., Johnson & Johnson Services, Inc., Perrigo Company plc, Novartis AG, The Harvard Drug Group LLC., Target Corp., Cigna, Habitrol, and Revolymer. Market players are focusing on the launch of innovative and novel products to cater to the evolving requirements of end-users.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: www.transparencymarketresearch.com

Tags

Related Articles

Close